Total Payments
$3,921
2024 Payments
$389.61
Companies
33
Transactions
265
Payment Breakdown by Category
Food & Beverage$3,875 (98.8%)
Education$46.41 (1.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,875 | 262 | 98.8% |
| Education | $46.41 | 3 | 1.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $550.75 | 33 | $0 (2024) |
| Amgen Inc. | $474.37 | 23 | $0 (2019) |
| PFIZER INC. | $423.43 | 37 | $0 (2024) |
| GlaxoSmithKline, LLC. | $342.72 | 25 | $0 (2024) |
| Merck Sharp & Dohme LLC | $306.17 | 25 | $0 (2022) |
| Lilly USA, LLC | $275.22 | 15 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $240.75 | 16 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $201.54 | 26 | $0 (2018) |
| E.R. Squibb & Sons, L.L.C. | $166.04 | 9 | $0 (2018) |
| Novo Nordisk Inc | $159.96 | 8 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $389.61 | 20 | Lilly USA, LLC ($76.49) |
| 2023 | $152.22 | 8 | PFIZER INC. ($63.20) |
| 2022 | $76.61 | 4 | Novo Nordisk Inc ($40.48) |
| 2019 | $275.48 | 15 | Amgen Inc. ($122.86) |
| 2018 | $1,437 | 101 | Boehringer Ingelheim Pharmaceuticals, Inc. ($268.40) |
| 2017 | $1,590 | 117 | Boehringer Ingelheim Pharmaceuticals, Inc. ($203.90) |
All Payment Transactions
265 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/14/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $23.09 | General |
| Category: Gastroenterology | ||||||
| 10/21/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.17 | General |
| Category: RESPIRATORY | ||||||
| 10/14/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.79 | General |
| Category: DIABETES | ||||||
| 10/08/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $28.94 | General |
| Category: Diabetes | ||||||
| 09/17/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $21.51 | General |
| 09/13/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $21.47 | General |
| Category: Cardio-renal | ||||||
| 09/09/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $18.84 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/19/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.15 | General |
| Category: DIABETES | ||||||
| 07/15/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $22.02 | General |
| Category: Diabetes | ||||||
| 06/24/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $22.89 | General |
| Category: Hematology | ||||||
| 06/12/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $19.62 | General |
| Category: Gastroenterology | ||||||
| 06/04/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $19.99 | General |
| Category: RESPIRATORY | ||||||
| 05/13/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $15.23 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/13/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.07 | General |
| Category: DIABETES | ||||||
| 05/07/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $16.10 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/29/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $20.64 | General |
| Category: Neuropsychiatry | ||||||
| 04/08/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.40 | General |
| Category: Diabetes | ||||||
| 03/26/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $25.53 | General |
| Category: Diabetes | ||||||
| 01/30/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $18.68 | General |
| Category: PAIN | ||||||
| 01/22/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.48 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/18/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $14.74 | General |
| Category: Diabetes | ||||||
| 05/25/2023 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $18.82 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 05/11/2023 | GlaxoSmithKline, LLC. | BEXSERO (Biological), ROTARIX, FLULAVAL QUADRIVALENT | Food and Beverage | In-kind items and services | $26.58 | General |
| Category: VACCINES | ||||||
| 04/20/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $18.83 | General |
| Category: Diabetes | ||||||
| 04/04/2023 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $21.90 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
About Dr. George Barth, M.D
Dr. George Barth, M.D is a Geriatric Medicine healthcare provider based in Waterbury, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1831200187.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. George Barth, M.D has received a total of $3,921 in payments from pharmaceutical and medical device companies, with $389.61 received in 2024. These payments were reported across 265 transactions from 33 companies. The most common payment nature is "Food and Beverage" ($3,875).
Ad
Practice Information
- Specialty Geriatric Medicine
- Other Specialties Hospice and Palliative Medicine, Family Medicine
- Location Waterbury, CT
- Active Since 08/31/2006
- Last Updated 03/22/2019
- Taxonomy Code 207QG0300X
- Entity Type Individual
- NPI Number 1831200187
Products in Payments
- JARDIANCE (Drug) $371.81
- Prolia (Biological) $320.96
- ELIQUIS (Drug) $276.58
- JANUVIA (Drug) $255.33
- CHANTIX (Drug) $203.54
- Repatha (Biological) $153.41
- INVOKANA (Drug) $152.04
- TRULICITY (Drug) $131.39
- XIFAXAN (Drug) $116.14
- TRELEGY ELLIPTA (Drug) $110.85
- FARXIGA (Drug) $103.83
- TOUJEO (Drug) $101.65
- MOUNJARO (Drug) $91.23
- ADVAIR (Drug) $70.90
- ANORO (Drug) $70.60
- Rybelsus (Drug) $59.31
- STIOLTO (Drug) $56.81
- VYVANSE (Drug) $55.41
- BYDUREON (Drug) $53.94
- Symtuza (Drug) $51.86
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.